These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2452445)

  • 1. Localization of a factor VIII-inhibiting antibody epitope to a region between residues 338 and 362 of factor VIII heavy chain.
    Ware J; Toomey JR; Stafford DW
    Proc Natl Acad Sci U S A; 1988 May; 85(9):3165-9. PubMed ID: 2452445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epitope localization of anti-factor VIII monoclonal antibodies determined by recombinant peptides.
    Ware J; Toomey JR; Stafford DW
    Thromb Haemost; 1989 Apr; 61(2):225-9. PubMed ID: 2473538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization of the binding regions of a murine monoclonal anti-factor VIII antibody and a human anti-factor VIII alloantibody, both of which inhibit factor VIII procoagulant activity, to amino acid residues threonine351-serine365 of the factor VIII heavy chain.
    Foster PA; Fulcher CA; Houghten RA; de Graaf Mahoney S; Zimmerman TS
    J Clin Invest; 1988 Jul; 82(1):123-8. PubMed ID: 2839543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fine epitope mapping of monoclonal antibodies to the NH2-terminal part of von Willebrand factor (vWF) by using recombinant and synthetic peptides: interest for the localization of the factor VIII binding domain.
    Jorieux S; Gaucher C; Piétu G; Chérel G; Meyer D; Mazurier C
    Br J Haematol; 1994 May; 87(1):113-8. PubMed ID: 7524613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Some factor VIII inhibitor antibodies recognize a common epitope corresponding to C2 domain amino acids 2248 through 2312, which overlap a phospholipid-binding site.
    Scandella D; Gilbert GE; Shima M; Nakai H; Eagleson C; Felch M; Prescott R; Rajalakshmi KJ; Hoyer LW; Saenko E
    Blood; 1995 Sep; 86(5):1811-9. PubMed ID: 7544643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A factor VIII neutralizing monoclonal antibody and a human inhibitor alloantibody recognizing epitopes in the C2 domain inhibit factor VIII binding to von Willebrand factor and to phosphatidylserine.
    Shima M; Scandella D; Yoshioka A; Nakai H; Tanaka I; Kamisue S; Terada S; Fukui H
    Thromb Haemost; 1993 Mar; 69(3):240-6. PubMed ID: 7682339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epitope mapping of human factor VIII inhibitor antibodies by site-directed mutagenesis of a factor VIII polypeptide.
    Ware J; MacDonald MJ; Lo M; de Graaf S; Fulcher CA
    Blood Coagul Fibrinolysis; 1992 Dec; 3(6):703-16. PubMed ID: 1283342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A synthetic factor VIII peptide of eight amino acid residues (1677-1684) contains the binding region of an anti-factor VIII antibody which inhibits the binding of factor VIII to von Willebrand factor.
    Foster PA; Fulcher CA; Houghten RA; Zimmerman TS
    Thromb Haemost; 1990 Jun; 63(3):403-6. PubMed ID: 2119526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A murine monoclonal anti-factor VIII inhibitory antibody and two human factor VIII inhibitors bind to different areas within a twenty amino acid segment of the acidic region of factor VIII heavy chain.
    Foster PA; Fulcher CA; Houghten RA; de Graaf Mahoney S; Zimmerman TS
    Blood Coagul Fibrinolysis; 1990; 1(1):9-15. PubMed ID: 2129392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterisation of an antibody specific for coagulation factor VIII that enhances factor VIII activity.
    Takeyama M; Nogami K; Matsumoto T; Soeda T; Suzuki T; Hattori K; Shima M
    Thromb Haemost; 2010 Jan; 103(1):94-102. PubMed ID: 20062922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A monoclonal antibody to von Willebrand factor (vWF) inhibits factor VIII binding. Localization of its antigenic determinant to a nonadecapeptide at the amino terminus of the mature vWF polypeptide.
    Bahou WF; Ginsburg D; Sikkink R; Litwiller R; Fass DN
    J Clin Invest; 1989 Jul; 84(1):56-61. PubMed ID: 2472430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A monoclonal antibody to factor VIII inhibits von Willebrand factor binding and thrombin cleavage.
    Precup JW; Kline BC; Fass DN
    Blood; 1991 May; 77(9):1929-36. PubMed ID: 1902121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epitope mapping via selection of anti-FVIII antibody-specific phage-presented peptide ligands that mimic the antibody binding sites.
    Kahle J; Orlowski A; Stichel D; Becker-Peters K; Kabiri A; Healey JF; Brettschneider K; Naumann A; Scherger AK; Lollar P; Schwabe D; Königs C
    Thromb Haemost; 2015 Feb; 113(2):396-405. PubMed ID: 25520269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Six amino acid residues in a 1200 Å2 interface mediate binding of factor VIII to an IgG4κ inhibitory antibody.
    Lin JC; Ettinger RA; Schuman JT; Zhang AH; Wamiq-Adhami M; Nguyen PC; Nakaya-Fletcher SM; Puranik K; Thompson AR; Pratt KP
    PLoS One; 2015; 10(1):e0116577. PubMed ID: 25615825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epitope localization of monoclonal antibodies against factor VIII light chain which inhibit complex formation by factor VIII with von Willebrand factor.
    Shima M; Yoshioka A; Nakai H; Tanaka I; Sawamoto Y; Kamisue S; Terada S; Fukui H
    Int J Hematol; 1991 Dec; 54(6):515-22. PubMed ID: 1724391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular analysis of human anti-factor VIII antibodies by V gene phage display identifies a new epitope in the acidic region following the A2 domain.
    van den Brink EN; Turenhout EA; Bank CM; Fijnvandraat K; Peters M; Voorberg J
    Blood; 2000 Jul; 96(2):540-5. PubMed ID: 10887116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a factor VIII immunogenic site using factor VIII synthetic peptide 1687-1695 and rabbit anti-peptide antibodies.
    Tiarks C; Pechet L; Anderson J; Mole JE; Humphreys RE
    Thromb Res; 1992 Feb; 65(3):301-10. PubMed ID: 1378653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epitope mapping of polyclonal clotting factor VIII-inhibitory antibodies using phage display.
    Mühle C; Schulz-Drost S; Khrenov AV; Saenko EL; Klinge J; Schneider H
    Thromb Haemost; 2004 Mar; 91(3):619-25. PubMed ID: 14983240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An immunogenic region within residues Val1670-Glu1684 of the factor VIII light chain induces antibodies which inhibit binding of factor VIII to von Willebrand factor.
    Foster PA; Fulcher CA; Houghten RA; Zimmerman TS
    J Biol Chem; 1988 Apr; 263(11):5230-4. PubMed ID: 2895765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a thrombin-interactive site within the FVIII A2 domain that is responsible for the cleavage at Arg372.
    Nogami K; Saenko EL; Takeyama M; Giddings JC; Yoshioka A; Shima M
    Br J Haematol; 2008 Feb; 140(4):433-43. PubMed ID: 18081893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.